Search Tag: Financial Report
2017 15 May
Accelerate Diagnostics, Inc. announced the closing of its previously announced underwritten public offering of 2,750,000 shares of its common stock, upsized from the original share offering of 2,500,000 shares of common stock, at a previously disclosed public offering price of $28.85 per share. The gross proceeds to Accelerate Diagnostics from the...Read more
2016 09 May
Q1 2016 Highlights (compared to Q1 2015): Total revenue, including royalties, rose 10.8% to $171.2 million Product revenue rose 10.8% to $163.3 million Masimo rainbow® revenue rose 39.2% to $16.9 million SET® and rainbow® SET® units shipments were 46,300 GAAP net income of $27.6 million, or $0.53 per diluted share versus $20.5 million, or $0.38...Read more